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Abstract The mission of the Italian Society of Colorectal
Surgery (SICCR) is to optimize patient care. Providing
evidence-based practice guidelines is therefore of key
importance. About the present report it concernes the
SICCR practice guidelines for the diagnosis and treatment
of diverticular disease of the colon. The guidelines are not
intended to define the sole standard of care but to provide
evidence-based recommendations regarding the available
therapeutic options.
Keywords Diverticulosis  Diverticular disease 
Diverticulitis  Colon
Methods
The literature on diverticular disease (DD) of the colon was
reviewed by a group of Italian experts joined by a foreign
expert on the topic (PG).
The final grade of recommendation was determined by
using the Grades of Recommendation, Assessment,
Development and Evaluation (GRADE) system [1]. Rec-
ommendations were reviewed by the Board of the Italian
Society of Colon and Rectal Surgery.
Definitions
Colonic diverticula are herniations of the mucosa and sub-
mucosa through the bowel muscular layer. Diverticulosis is
merely the presence of colonic diverticula: if symptoms and/
or complications appear, we talk of diverticular disease
(DD). Symptomatic uncomplicated diverticular disease
(SUDD) is defined as mild, recurring abdominal pain
attributed to diverticula and may be difficult to distinguish
from irritable bowel syndrome (IBS) [2, 3]. Complicated
diverticular disease (CDD) is DD with inflammation and
possibly bleeding: the type of onset and duration of symp-
toms differentiate acute from chronic CDD. The inflam-
mation, by far the most frequent and due to more or less
severe diverticular perforation, is called diverticulitis. The
presentation of acute diverticulitis (AD) could range from a
localized, mild pain and/or tenderness, to an abdominal
abscess or a free perforation with diffuse peritonitis. Dif-
ferent classifications of AD have been proposed, and the
most utilized is the Hinchey classification [4].
Recurrent episodes of AD could lead to chronic CDD,
mainly identified in as the presence of symptomatic chronic
bowel stenosis or fistulization, usually colovesical or
colouterine fistulas.
Epidemiology
DD imposes a significant burden on Western and indus-
trialized societies.
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The prevalence of diverticulosis increases with age,
affecting about 70 % of 80-year-olds, and is increasing
because the population is getting older [5]. From 10 to
25 % of individuals with diverticulosis develop complica-
tions such as diverticulitis [6].
Hospitalizations for diverticular disease have also been
on the rise [7–9].
Recent literature has reported an increase in the inci-
dence of DD among younger patients. In a large review of
the Nationwide Inpatient Sample (NIS) of 267,000
admissions for AD between 1998 and 2005 [7], incidence
rates increased most dramatically in 18- to 44-year-olds
and 45- to 64-year-olds, while they remained stable in 65-
to 74-year-olds and actually decreased in persons 75 years
of age or older.
In summary, the prevalence of diverticulosis and DD is
increasing in Western countries and there has been an
increasing rate of hospital admission for diverticulitis.
Moreover, there is increasing incidence among individuals
younger than 40 years of age (Evidence: 2c).
Pathophysiology
The pathophysiology of DD can be categorized as (a) di-
verticula development, (b) symptoms generation in
uncomplicated DD and (c) development of diverticulitis.
Lifestyle factors are considered key elements for the
development of diverticulosis and its complications. A
low-fibre diet appears to play a major role as it appears
from case control and prospective dietary studies [10–13].
The low-fibre hypothesis has recently been disputed [14–
17]. A study on 2104 individuals undergoing colonoscopy
showed that a high-fibre intake was positively associated
with the presence of diverticulosis (prevalence
ratio = 1.30 95 % confidence interval (CI), 1.13–1.50)
[18]. Genetic factors may also play a role [14].
Up to 20 % of individuals with diverticula experience
abdominal pain associated with abnormal motor function
and a reduced threshold for perception of visceral sensi-
tivity [17], similarly to individuals with IBS [18]. An
increased number of mast cells in all the layers of the
colonic wall may contribute to pain development [19].
Trauma caused by faecoliths may cause epithelial break-
down and bacterial translocation, which may lead to
diverticulitis. Examination of mucosal biopsies from
symptomatic DD showed low-grade inflammation (i.e.
lymphocytes and neutrophils) despite endoscopically nor-
mal mucosa [20]. Post-inflammatory gut dysfunction fol-
lowing acute infectious gastroenteritis (post-infectious
IBS) is a condition similar to diverticulitis [21]. Indeed, a
recent study showed that patients with diverticulitis were
4.7 times more likely to develop IBS-like symptoms over
the observation period compared to matched controls [22].
Diagnostic tests
What is the best diagnostic test to confirm or rule
out diverticulosis?
We recommend either computed tomographic colonogra-
phy (CTC) or colonoscopy (CS) as the most accurate
imaging tests to diagnose or exclude colonic diverticulosis.
The choice of CTC or CS depends on the patient’s pref-
erence, age, clinical status and risk factors for colorectal
cancer (CRC) (1C). Double-contrast barium enema
(DCBE) is an alternative only if CTC is unavailable (1B).
Since CTC offers better diagnostic accuracy [23], less
invasiveness and a lower complication rate than CS, it can
be chosen as a first-line modality and is the test of choice in
elderly and frail patients with potential contraindications to
CS and sedation. On the other hand, in young patients
(\40 years) where the prevalence of DD is low and the
possibility of colonic inflammation is higher, CS might be
the first choice [24, 25].
DCBE can effectively diagnose diverticulosis [26–28]
but is limited by lower compliance [29], longer examina-
tion time, higher number of complications [30], absent
evaluations of extracolonic findings and higher radiation
exposure [31–34] (1–5 mSv with CTC, 7–9 mSv with
DBCE). Ultrasonography (US) plays a very limited role
[35], while magnetic resonance colonography (MRC) is a
promising alternative due to the lack of ionizing radiation
[36, 37]. However, it is more time-consuming and prone to
motion artefacts than CTC.
What diagnostic test should be used in patients presenting
with acute abdominal symptoms and clinical suspicion
of diverticulitis?
We recommend multidetector computed tomography
(MDCT) with intravenous administration of contrast
medium (CM) as the first-line colon examination in
patients with symptoms suggesting AD (1A).
In case of a patient presenting in an acute setting with
fever and laboratory findings of active inflammation, CE-
MDCT is the best examination [38–41] since clinical
evaluation has low sensitivity in these settings (about
64 %) [38]. MDCT is able to evaluate complicated and
uncomplicated forms, detect life-threatening complications
[42], stage the severity of diverticulitis, provide an alter-
native diagnosis in patients without diverticulitis and guide
therapeutic intervention [43, 44].
A recent meta-analysis of prospective performance
studies of CT versus US in AD showed similar sensitivity
(95 %) but higher specificity for CT [45]. Therefore, in
order to minimize the risk of ionizing radiation, a strategy
where CT scan follows a preliminary negative or
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inconclusive US might be advantageous, because the
number of CT exams can be reduced by about 50 % [46,
47].
The use of DBCE should be discouraged in acute set-
tings [48, 49].
Performance of MRC in diagnosing acute diverticulitis
has been examined in two small studies [50, 51] showing
good sensitivity (about 95 %) and specificity (about 88 %).
However, feasibility is limited by the difficult access to
MRC in emergency departments.
What diagnostic test should be used to follow-up patients
with DD?
We suggest CS as the imaging modality of choice to fol-
low-up patients after an episode of AD. CTC might become
a valuable alternative particularly because of patient pref-
erence, but no evidence-based data are available at the
moment to sustain this hypothesis (1C).
After an episode of AD, a colonic investigation is
required to confirm the diagnosis and to rule out malig-
nancy, although evidence-based data are not available.
Thus, in clinical practice, colonic investigation is often
performed only in those patients with persistent colonic
symptoms after the resolution of the acute episode [24]. CS
has been reported to be more difficult than CTC with a
higher risk of vasovagal reactions and complications such
as perforation and haemorrhage [52–54]. Thus, CTC might
be considered a valid alternative. It has high diagnostic
accuracy for polyps and cancer and for findings specific for
DD (focal wall thickening, reduced lumen diameter, pres-
ence of diverticula) [55]. Moreover, several articles have
reported better tolerability for CTC than for CS [55–57].
Therapy
Should diverticulosis without abdominal symptoms be
treated?
We suggest that diverticulosis should not be treated phar-
macologically. A high-fibre diet should be encouraged, but
the evidence that it prevents DD is limited (1C).
Crowe et al. [12] documented that vegetarian and high-
fibre diets are associated with a lower risk of admission to
hospital or death from DD. Similar results have been
obtained by Aldoori et al. [58] Evidence indicates that
insoluble fibre is strongly associated with lower risk of DD
and this association was particularly strong for cellulose
[58, 59]. A recent systematic review evaluates the thera-
peutic effect of fibre supplements on DD symptoms. Fibre
supplementation alone provides controversial results in
terms of symptom relief [60]. There is no rationale to avoid
the consumption of nut, corn and popcorn to prevent
diverticular complications, as shown in a large, prospective
study, the exclusion from the diet of these foods to prevent
diverticular complications was not effective [14].
Which treatment regimen should be employed
in symptomatic uncomplicated DD?
We suggest that some patients may benefit of rifaximin
associated with fibre and some from mesalazine alone.
However, the most effective duration of therapy and
number of doses has not been determined. Evidence is
limited at 1- to 2-year follow-up (1B).
There is insufficient evidence that treatment with pro-
biotics is effective in reducing symptoms (2B).
A recent systematic review suggests the potential use-
fulness of rifaximin, mesalamine, fibre and probiotics, and
their possible combinations in the treatment of symp-
tomatic uncomplicated diverticular disease, but reliable
controlled therapeutic trials are not available [61].
Data suggest that the cyclic treatment with non-ab-
sorbable antibiotics plus high-fibre diet is more effective in
obtaining symptom relief than fibre alone [62, 63]. The
rationale for the use of non-absorbable antibiotics like
rifaximin in colonic DD is that stasis of luminal contents
can lead to bacterial overgrowth [64] which in turn may
give rise to chronic low-grade mucosal inflammation [65].
It has been shown that rifaximin could be useful in IBS and
small bowel bacterial overgrowth by reducing bloating,
abdominal pain, flatulence and loose stools [66]. A meta-
analysis found that 64 % of patients treated with rifaximin
plus standard fibre supplement were symptom free at
1-year follow-up, compared with 34.9 % of patients treated
with fibre alone [67].
It has been proposed that the chronic inflammation in
DD is similar to that in inflammatory bowel disease (IBD)
[68]. For this reason, 5-aminosalicylic acid (5-ASA) drugs
that are commonly used in IBD have been studied in the
management of SUDD [69]. Mesalazine has been investi-
gated in multiple studies as a single agent to achieve and to
maintain remission [70, 71]. Mesalazine has demonstrated
greater complete symptom response than placebo [72, 73].
Mesalamine has also been studied in combination with
rifaximin in patients with recurrent diverticulitis and
SUDD suggesting that mesalazine was as effective as
rifaximin for diminishing some of the symptoms, but it was
better than rifaximin for improving the total symptom score
[74, 75].
Considering dosage (800–3000 mg), timing (bid vs. tid),
length (4 weeks–1 year) and modality (continuous vs. 7 or
10 days/month) of treatment, superiority of one regimen
versus another has not been tested in clinical trials, and
therefore, treatment should be adapted to the individual
patient.
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The rationale for the use of probiotics in symptomatic
DD is formed by their anti-inflammatory effects and
capability to enhance the immune response [76–78]. A
recent review suggests that therapy with probiotics is safe
and potentially useful in the management of patients with
DD [79]. Three studies investigated the efficacy of Lac-
tobacillus casei together with mesalazine on reduction of
abdominal symptoms in patients with DD [80, 81] showing
that the use of probiotics was at least equivalent to the use
of the anti-inflammatory drug [80] and enhanced its ben-
eficial effect [80–82]. In a study [83] that investigated a
multistrain probiotic (Streptococcus thermophilus, Bifi-
dobacteriaand and Lactobacilli) together with another anti-
inflammatory drug, balsalazide, both treatment arms were
effective in reducing abdominal symptoms without a sta-
tistically significance difference between groups (73 vs.
60 %).
Three further studies investigated the efficacy of Lac-
tobacillus acidophilus, L. helveticus and Bifidobacterium
spp. 420 or Lactobacillus paracasei in patients with
uncomplicated DD observing a reduction in abdominal
pain and bloating [84–86]. Albeit small and uncontrolled,
these studies suggest that probiotics may be effective in the
management of DD. Larger randomized, placebo-con-
trolled studies would be needed before probiotics can be
definitely recommended in the management of DD.
What therapy regimen should be used to prevent
recurrence of diverticulitis?
Fibre plus rifaximin is more effective than fibre alone in
preventing AD with a low therapeutic advantage. There is
no substantial evidence that mesalazine alone is effective in
preventing recurrence of diverticulitis (1B).
A meta-analysis of 4 RCTs has studied the ability of
rifaximin (added to fibre treatment) to prevent acute
diverticulitis in patients with colonic diverticular disease,
the pooled rate difference used as a measure of the thera-
peutic effect in the treatment group was -1.9 % (95 % CI
-3.4 to -0.6 %, p = 0.0057), and the number needed to
treat was 50 [67].
Moreover, a recent multicenter, randomized, open study
investigated the efficacy of rifaximin (plus high-fibre
intake) in the secondary prevention of AD. Recurrences
occurred in 10.4 % of patients given rifaximin plus fibre
versus 19.3 % of patients receiving fibre alone (p = 0.033)
[87]. Despite the methodological limitations, this study
suggests that cyclic rifaximin treatment has the potential to
prevent recurrence of diverticulitis in patients with colonic
DD [88]. However, the level of evidence of superiority of
non-absorbable antibiotics over dietary fibre or fibre sup-
plementation is poor [89], and both the cost and efficacy of
a long-life cyclic treatment with non-absorbable antibiotics
to prevent diverticulitis in all patients with symptomatic
DD have been questioned [61].
The efficacy of mesalazine in preventing recurrence of
AD was the primary end point of two recently published
RCT placebo studies which failed to show a significant
efficacy of mesalazine alone or combined with probiotics
over placebo in a follow-up of 12 and 24 months [72,
90]. Some open randomized studies assessed the effec-
tiveness of mesalazine. Except for one study, which
failed to show any effectiveness of medical therapy in
preventing AD in patients with uncomplicated DD [91],
the others, conducted on patients with recent attacks of
AD, showed that 7 days/month therapy with mesalazine
alone or combined with rifaximin was significantly more
effective than rifaximin alone in preventing recurrences
of AD in 12- and 24-month follow-up [74, 92]. However,
recent results of a robust RCT, where the patients were
treated for 2 years, showed that mesalazine was not
superior to placebo in preventing recurrent diverticulitis,
thus making this treatment highly questionable for this
condition [93].
Does acute uncomplicated diverticulitis need antibiotic
treatment?
We suggest avoiding antibiotic in acute uncomplicated
diverticulitis since may not improve short- or long-term
outcomes. Use on a case-by-case basis should possibly be
considered (1B).
Recently strong evidence from a large RCT showing no
benefit of antibiotics in AD raised important questions
about the aetiology and management of diverticulitis [94,
95]. It has been argued that AD may be an inflammatory
rather than an infectious condition [96] making the use of
antibiotics questionable.
In a retrospective audit of 311 patients hospitalized for
AD, it was observed that antibiotic or conservative treat-
ment yielded the same clinical outcome, with an overlap-
ping rate of recurrence [97]. The so-called DIABOLO trial
(more than 500 patients, Hinchey stage 1a or 1b), a ran-
domized multicentre clinical trial comparing two treatment
strategies for AD, is ongoing [98]. Patients will be ran-
domized to a conservative strategy (antibiotics for 10 days,
hospital admission, supportive measures) or to a liberal
strategy (no antibiotics, supportive measures and admission
only if needed on clinical grounds). The study should be
completed by the end of 2014 and will surely provide
objective evidence for clinical decisions. At the present
time, however, there is no evidence mandating the routine
use of antibiotics in AD, despite several guidelines rec-
ommending their use [99, 100].
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Does acute uncomplicated diverticulitis (CT confirmed)
need hospitalization?
We suggest that an ambulatory treatment protocol is safe
and effective for a majority of patients and it is justified in
clinical practice (1A).
Four studies compared outpatient versus inpatient
treatment [101–104]. One RCT (the DIVER Trial) con-
ducted on 132 AD patients has shown that, in selected
patients, outpatient treatment is safe and effective [103]. In
a recent RCT, 623 patients with CT-verified acute
uncomplicated left-sided diverticulitis were recruited.
Patients were randomized to treatment with or without
antibiotics, and antibiotic use neither accelerated recovery
nor prevented complications. Recurrent diverticulitis was
similar in the two groups [94]. Recent systematic reviews
pointed out that a more progressive, ambulatory-based
approach to the majority of cases of acute uncomplicated
diverticulitis should be encouraged [105]. This new evi-
dence needs, however, further confirmations before it can
be safely adopted in clinical practice [106]. In patients who
have comorbidities and/or are immunocompromised, hos-
pitalization should still be considered a good option.
Elective surgery for diverticular disease
Is there a role for prophylactic interval colectomy after one
or more episodes of AD?
We recommend that the decision to perform elective
resection after one or more episodes of AD should be
undertaken on a ‘‘case by case’’ basis (1C).
In the late 1990s, three scientific associations, the
American Society of Colon and Rectal Surgeons (ASCRS),
the European Association for Endoscopic Surgery (EAES)
and the American College of Gastroenterology (ACG)
[107–109], agreed on the necessity of prophylactic interval
sigmoidectomy after two previous episodes of acute
diverticulitis (AD), or one episode only if the patient was
under 50. This statement was mainly based on outdated
studies by Parks [110] and Farmakis [111], which sug-
gested that with each further episode of diverticulitis, there
was a higher probability of recurrent attacks with less
chances of response to medical treatment and an increasing
risk of complicated diverticulitis (as high as 60 %) with a
doubling of the mortality rate. A review by Janes in 2005
[112] concluded that these studies give ‘‘inadequate evi-
dence’’ to support such an aggressive surgical policy. In
2006, one of these associations (ASCRS) already adopted a
more prudent policy, considering the indication for elective
surgery on a ‘‘case by case’’ basis [113].
More recently, many studies have questioned these
indications primarily because the majority of patients
experience an acute complication at their first presentation
of DD, the long-term risk of relapse is quite low [114–118],
recurrent episodes of uncomplicated diverticulitis do not
lead to failure of conservative treatment or to an increased
risk of poor outcomes if patients develop complicated
diverticulitis [119, 120], and most important of all, the
long-term risks of subsequent emergent surgery, stoma
formation and death are low [114, 115, 121–123]. More-
over, the risk of severe complications, as perforation, is
usually associated with the first episode of AD [112, 119–
121, 124]. A recent nationwide study [125] confirms that a
less aggressive strategy is not associated with an increase
in complicated diverticulitis at recurrence. Moreover, a
retrospective, statewide study on 84,313 patients admitted
for diverticulitis from 1987 to 2012, the period of time in
which the elective colectomy rate doubled, failed to show a
decrease in emergency surgery or admission for divertic-
ulitis [126].
Furthermore, surgery for diverticulitis does not seem to
fully protect against the risk of recurrence since the inci-
dence of recurrent attacks is between 5.8 and 15 % [111,
115, 127], and risk of further surgery is up to 3 % [112,
115, 128, 129].
In conclusion, the indication for elective sigmoid
resection should not be based on the number of previous
episodes of AD [112, 113, 130].
What are the actual indications for elective surgery?
Elective surgery should be recommended to patients with
symptomatic complicated DD (fistula, stenosis). Specific
clinical situations should be carefully evaluated (persisting
symptoms and signs, age, degree of diverticulitis, immune-
compromised patients) (1C).
The first step is to connect the symptoms to DD as
the differential diagnosis with IBS, segmental colitis
associated with diverticulosis (SCAD), or other colitis
very challenging. If symptoms are clearly connected with
DD, their severity has to be balanced with operative
risks (i.e. age, body mass index, comorbidities and
specific surgical complications) and the risk of severe
complications.
Age should not be considered an indication for more
aggressive surgery. It has been reported that younger
patients are more prone to recurrent disease and more
frequently require surgery [131–135], but more recent
studies suggested that age is not a predictive factor of poor
outcome [114, 136–139]. Similarly, the cut-off age (40 or
50 years) to identify patients at increased risk of recurrence
is also controversial.
Immunocompromised patients or patients on immuno-
suppressive therapy, patients with chronic renal failure or
collagen vascular disease had a fivefold greater risk of
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perforation in a recurrent episode of AD [119, 130, 140],
and therefore, these patients may benefit from an early
elective resection after a conservatively treated episode of
diverticulitis. This statement has been challenged by a
study on 166 immunosuppressed patients that showed that
they had a significantly higher mortality rate than non-
immunosuppressed patients, but only during the first epi-
sode of the disease, and that patients who required emer-
gency surgery for AD had no previous history of
diverticular disease [141]. Therefore, no firm conclusions
can be drawn about the need of elective, prophylactic
sigmoidectomy in immunocompromised patients.
Based on Ambrosetti’s classification, the degree of
diverticulitis on CT is predictive of long-term outcome.
After successful medical treatment of the acute episode,
patients with severe diverticulitis on CT had a statistically
greater incidence of secondary bad outcome than patients
with moderate diverticulitis (36 vs. 17 %) [142, 143].
Hall [144] showed in a multivariate analysis of 672
patents that left-sided AD, length of involved colon
[5 cm and a retroperitoneal abscess were predictors for
recurrence. However, the study could not report a multi-
variate model for complicated recurrence because of the
small number of events. The extent but not the severity of
diverticulitis may be associated with a higher risk of
recurrence but could not be considered an independent
risk factor.
In conclusion, there is no clear evidence that one single
risk factor could be considered an independent indication
for elective surgery for DD.
Surgical technique
What is the best timing for elective surgery?
We recommend that an elective colon resection for diver-
ticulitis should be performed in an inflammation-free
interval after complete remission of the acute inflammation
(1B).
Choosing the optimal time for elective surgery follow-
ing an episode of AD is important to minimize the risk of
intraoperative complications, caused by oedema, acute
inflammation, adhesions causing difficulty in identifying
the right planes and ureter, and any resulting perioperative
complications (fistula, leakage, haematoma or abscess).
Early elective surgery was initially considered to be at
lower risk [145]. However, Natarjan [146] and Hoffman
[147] found no outcome difference in their retrospective
case control studies. A prospective comparison of early and
late laparoscopic resection showed a significantly higher
rate of anastomotic leak, abdominal abscess, hospital stay
and conversion rate during early elective surgery [148].
Similar results are reported by Zingg [149].
What is the optimal distal level of resection?
We suggest that anastomosis after resection for DD be
made between the colon and the rectum with complete
resection of the sigmoid colon, although there is poor
evidence that constructing an anastomosis on the rectum
prevents symptoms and recurrent AD (2B).
There are two old retrospective studies [128, 150]
showing a significant reduction in symptoms and recurrent
AD when a colorectal anastomosis was constructed, after
resection of the entire sigmoid colon. In a prospective
study conducted by Binda [115] on 242 patients followed
for more than 10 years after surgery, recurrence or per-
sisting symptoms were not associated with the level of
resection.
What is the best level of vascular ligation?
We suggest that, if malignancy is ruled out preoperatively,
the inferior mesenteric artery (IMA) may be preserved in
selected patients if it does not reduce the safety of the
procedure, although the evidence is limited (2C).
In elective sigmoidectomy for diverticulitis, ligation of
the IMA is not mandatory, although it can facilitate iden-
tification of the ureter in patients with severe perisigmoid
inflammation and/or adhesions. On the other hand, its
preservation may improve the blood supply of the anasto-
mosis and avoid damage to the pre-aortic nerves. However,
in a recent meta-analysis [151] the leak rate was 7.3 % in
the IMA preservation group versus 11.3 % in the ligation
group, a difference which was not statistically significant.
The only randomized study included patients undergoing
open surgery and was considered of poor quality [151].
Preservation of the IMA is also achievable laparoscopi-
cally: however, two studies on laparoscopic resection for
DD show similar effects on sexual and urinary function
with [152] or without [153] IMA preservation.
In conclusion, there is limited evidence that there may
be a benefit in preserving the IMA. Further studies are
needed to clarify advantage and disadvantages of IMA
ligation.
Can elective surgery be performed through a laparoscopic
access?
We recommend laparoscopic access for elective colon
resection for uncomplicated diverticulitis, but it has to be
performed by well-trained surgeons. Laparoscopy has
short-term advantages over open surgery in terms of blood
loss, post-operative ileus, morbidity, hospital stay and
overall costs (1B).
A meta-analysis by Siddiqui on 2383 patients, compar-
ing open and laparoscopic sigmoid colectomy,
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demonstrated that laparoscopic sigmoid resection is asso-
ciated with less of the following post-operative complica-
tions: wound infection, post-operative ileus, transfusion
and incisional hernia [154]. In two prospective randomized
trials (PRTs) [155, 156], laparoscopy was shown to reduce
blood loss, pain (fewer analgesic requirements) and length
of hospital stay and to improve quality of life. The con-
version rate is approximately 9 %, but it less (3 %) if the
procedure is performed by expert surgeons [157]. In
addition, laparoscopic sigmoid resection is more cost-ef-
fective [158].
What are the indications for urgent surgery?
We suggest urgent surgery for patients with diffuse peri-
tonitis and for those who fail to improve despite appro-
priate medical therapy (2B).
About 15–20 % of patients hospitalized for AD undergo
emergency surgery [159, 160]. The majority of them have
symptoms and signs of diffuse peritonitis, and/or pneu-
moperitoneum at admission. The remainder fail to improve
promptly despite an appropriate medical approach. As
regards the latter group, there is no information on the
optimal timing for surgery, and the decision should be
based on clinical and imaging features. Even if non-oper-
ative management has been adopted in selected stable
patients with diverticular perforation and pneumoperi-
toneum, further studies are needed in order to establish the
efficacy and safety of such an approach [161, 162].
What are the treatment options for feculent peritonitis?
We recommend that patients with diverticular perforation
and feculent peritonitis (Hinchey IV) undergo urgent sig-
moid resection without restoration of bowel continuity. The
appropriateness of resection and primary anastomosis has
not been clearly established (2B).
A number of studies, including 2 RCTs, have compared
the efficacy and safety of primary anastomosis with those
of non-restorative surgery (Hartmann’s procedure) in
patients with diverticular perforation and diffuse peritonitis
[163–166].
Even if both techniques have shown similar results in
terms of efficacy, when considering feculent peritonitis the
number of accrued patients is still inadequate to challenge
the established use of non-restorative surgery [163, 164].
What are the treatment options for purulent peritonitis?
We suggest that sigmoid resection and primary anasto-
mosis with or without proximal diversion are the appro-
priate surgical option for AD with diffuse purulent
peritonitis (Hinchey III). Laparoscopic lavage/drainage
combined with antibiotics may be an alternative, but
specific indications have not been defined. Hartmann’s
procedure has to be adopted when a primary anastomosis is
judged unsafe (1B).
For patients with diverticular perforation and purulent
peritonitis, several surgical options may be appropriate
depending on the severity of intra-abdominal and general
conditions.
Two prematurely interrupted RCTs [163, 164] and
several studies with weaker methodology [165, 166] have
demonstrated similar mortality and morbidity after resec-
tion with primary anastomosis and non-restorative proce-
dures: it seems highly unlikely that an exhaustive RCT will
be performed [167].
Similarly, a RCT (the DILALA study) has shown that
morbidity and 90-day mortality after laparoscopic lavage
are the same as after Hartmann’s procedure [168]. How-
ever, a word of caution is in order, as the mortality rate of
patients undergoing laparoscopic lavage was substantially
higher than previously reported [169]. Moreover, another
RCT has stopped accrual in the laparoscopic lavage arm
due to safety concerns [170].
Besides, eventual specific criteria for choosing between
resection with primary anastomosis and laparoscopic
lavage are still undefined.
Hartmann’s procedure is advisable when a patient is
hemodynamically unstable or has intra-abdominal condi-
tions which make primary anastomosis unsafe.
What are the treatment options for diverticular abscess?
We recommend the guided percutaneous drainage com-
bined with antibiotics as the preferable treatment for
C4 cm diverticular abscesses. Those abscesses not
responding to or not amenable to non-operative manage-
ment should be treated surgically (2A).
Though solid supporting evidence is lacking, most
abscesses B3 cm in diameter can be treated safely and
successfully with antibiotics alone, while larger abscesses
most often require combined percutaneous drainage and
antibiotics [171–173]. There is no evidence supporting a
specific drainage or aspiration technique.
Patients with diverticulitis-related abscesses that are not
drainable or who do not respond to percutaneous treatment
should undergo urgent surgery [173]. There is no agree-
ment nor evidence supporting a conservative or surgical
regimen for abscesses treated successfully by guided per-
cutaneous drainage [173].
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